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Abstract
This study assesses malaria prevention and treatment behaviour among people living with
HIV/AIDS (PLWHA) in Owerri, South Eastern Nigeria. Although Nigeria bears one of the
world’s largest burdens of both malaria and HIV, there is almost no research studying how
co-infected patients manage their care. We systematically sampled 398 PLWHA receiving
care at Imo State Specialist Hospital and the Federal Medical Centre in Owerri to complete
a structured, pre-tested questionnaire on malaria care-seeking behaviour. Descriptive sta-
tistics were reported and chi-square tests and multivariate logistic regressions were also
used. The majority of HIV-infected patients (78.9%) reported having had an episode of sus-
pected malaria quarterly or more often. There was a large variation in care-seeking patterns:
on suspicion of malaria, 29.1% of participants engaged in self-medication; 39.2% went to
drug shops, and only 22.6% visited HIV/AIDS care centres. Almost 40% waited more than
24 hours before initiating treatment. Most (60.3%), reported taking recommended artemisi-
nin-based combination treatments (ACT) but a significant minority took only paracetamol
(25.6%) or herbal remedies (3.5%). Most (80%) finished their chosen course of treatment;
and completion of treatment was significantly associated with the frequency of suspected
malaria occurrence (p = 0.03). Most (62.8%) did not take anti-malaria medication while tak-
ing antiretroviral treatment (ART) and almost all (87.6%) reported taking an ACT regimen
that could potentially interact with Nigeria’s first-line ART regimen. Our findings suggest the
need to pay more attention to malaria prevention and control as a crucial element in HIV/
AIDS management in this part of Nigeria and other areas where malaria and HIV/AIDS are
co-endemic. Also, more research on ART-ACT interactions, better outreach to community-
level drug shops and other private sector stakeholders, and clearer guidelines for clinicians
and patients on preventing and managing co-infection may be needed. This will require
improved collaboration between programmes for both diseases.
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Introduction
Malaria and HIV/AIDS overlap geographically in sub-Saharan Africa, Southeast Asia, and
South America. Both diseases pose enormous global health challenges with each causing over
three million deaths in 2007 and adversely affecting millions more each year [1, 2]. Nigeria has
the world’s largest malaria burden with more than 50 million cases annually and approxi-
mately 200,000 malaria-related deaths each year [3]. It also has the world’s second largest HIV/
AIDS burden, with approximately 3.6 million people living with HIV/AIDS in 2016 [4]. In
Imo State, South Eastern Nigeria, an area reported to be holo-endemic for malaria [5], the
HIV prevalence rate is now 7.5%, which is above the national average of 3.0% [6].
Co-infection with malaria and HIV can make each disease more severe and potentially more
infectious. Studies have shown that malaria infection increases plasma HIV viral load even with
asymptomatic parasitaemia [7–9]. In turn, the risk of parasitaemia and malarial fever increase
with decreasing CD4 cell counts and increasing viral load [8, 10]. Although early studies found
little association between HIV and malaria disease severity in either adults or children [11, 12],
it has subsequently been demonstrated that HIV infection predisposes both to more frequent
episodes of symptomatic malaria [13] and more episodes of severe or complicated malaria,
including death [14]. HIV-malaria co-infection is particularly serious for pregnant women in
whom complications such as life-threatening anaemia and placental malaria infection are com-
mon [15]. Individuals in malaria-endemic areas who are considered semi-immune to malaria
are still more likely to develop clinical malaria if they are infected with HIV [16].
Co-morbidity also complicates treatment for both diseases as many standard, first-line
treatments for malaria and for HIV interact; placing people living with HIV/AIDS (PLWHA)
at high risk of harmful adverse events including hepatotoxicity if incorrect antiretroviral drug
regimens are prescribed [17–19]. If patients stop antiretroviral HIV treatment while co-
infected, this incomplete or interrupted treatment can lead to resistance, making further treat-
ment more difficult and costlier. In addition, poorly managed HIV infection reduces responses
to malaria treatment by weakening the immune system. For example, the effectiveness of arte-
misinin, sulfadoxine-pyrimethamine, and artemether-lumefantrine have been found to vary in
PLWHA [20].
Considering the high rates of co-morbidity and the significant treatment challenges posed
by malaria and HIV co-infection, it is important to understand how PLWHA are currently
preventing and treating malaria. However, while there is an extensive literature on malaria
care-seeking behaviour in Africa [19–23] there are almost no studies of the malaria care-seek-
ing behaviour of PLWHA in general, and those receiving antiretroviral treatment (ART) in
particular. As a result, we know little about the care-seeking behaviour and patterns of malaria
prevention and treatment among PLWHA. We might suspect that the behaviour of PLWHA
might differ from that of the general population given their intense contact with the health sys-
tem and the relatively high level of resources available in HIV-treatment facilities.
This study therefore aims to describe malaria care-seeking behaviours among HIV-infected
patients receiving antiretroviral treatment in South-Eastern Nigeria. Our specific research
questions are: 1) How common is self-reported malaria co-infection among this sample of
PLWHA? 2) To what extent do PLWHA in our sample use informal services (including self-
treatment) to diagnose and treat suspected malaria? 3) What medications do PLWHA in our
sample use to treat suspected malaria? 4) Do PLWHA alter their antiretroviral treatment prac-
tices when taking anti-malarial drugs?
It is hoped that the study results will provide information to inform the development and
application of effective interventions that would improve the prevention and management of
malaria among HIV-infected patients.
Malaria care-seeking behaviour among HIV patients
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Materials and methods
Study location
The study was carried out in Owerri, South Eastern Nigeria, at the Imo State Specialist Hospital
(IMSSH) and the Heart-to-Heart unit of the Federal Medical Centre (FMC). The HIV care cen-
tres in these facilities are among the major sources of comprehensive HIV treatment and sup-
port for PLWHA in South Eastern Nigeria. South-Eastern Nigeria is one of the geopolitical
zones in Nigeria, consisting of five states and inhabited by the Igbo-speaking ethnic group. The
area covers a landmass of 41,440 km2, characterized by tropical rainforest vegetation. Apart
from state capitals and a few other urban towns, the area is rural. South-Eastern Nigeria has two
distinct seasons, the rainy and the dry seasons. Its climate and environment provide favourable
conditions for the breeding of the mosquito vector and malaria endemicity. The area has many
socioeconomic characteristics that increase the population-level risk of HIV infections. Malaria
co-infection among asymptomatic and symptomatic HIV seropositive individuals in South-
Eastern Nigeria has been reported to be 11.8% and 33.3% respectively [24].
Study design
The study has a descriptive, cross-sectional design. The study population comprised of all
patients living with HIV registered in Imo State Specialist Hospital in Owerri and Federal
Medical Centre in Owerri, from October 1 to December 31, 2017, as noted in hospital records
(N = 2,300). The study sample size was determined using the Taro Yamane method for sur-
vey-related studies [25], to obtain a minimum sample size of 341.
n ¼
N
1þ Nðe2Þ
ð1Þ
Because of HIV-related stigma and the tendency for PLWHA to shy away from public activi-
ties, we envisaged that a significant proportion of HIV-infected patients would decline to partici-
pate in the study. We, therefore, oversampled an additional 20% of the calculated sample size to
account for attrition and arrived at a sample size of 409. However, nine of the selected partici-
pants did not give consent to participate in the study, leaving us with the final sample size of 398.
Sampling technique
Systematic sampling was used to select study subjects from both study HIV care centres. We
sampled patients over four weeks (two weeks for each centre) during the clinic appointment
days for PLWHA. Initially, the number of eligible participants was obtained from the records
at each HIV care centre. Only those who were available on the appointment days were selected.
On each appointment day, we first divided the number of expected patients who had appoint-
ments as listed on the health centre’s records, by the required sample size to obtain an interval
number. This interval number was then used to systematically sample patients as they arrived
for their appointments on their respective appointment days. For example, if the day’s interval
was five, each fifth patient who arrived for an appointment was recruited to participate in the
study. In situations when a selected patient declined to consent to participate, the next patient
to arrive was selected. The records were crosschecked to ensure that subjects were not selected
more than once.
Development and pre-testing of study instrument
The instrument for data collection was a structured pre-tested questionnaire (see S1 Appen-
dix). The questionnaire was developed by the study researchers in collaboration with three
Malaria care-seeking behaviour among HIV patients
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HIV experts. The questionnaire was pre-tested using 30 HIV-infected patients at another,
non-study, HIV care centre in Imo state. The questionnaire contained 37 open- and closed-
ended questions on the respondents’ demographic background; HIV treatment history; and
malaria care-seeking behaviour; including the frequency of malaria episodes; type, source and
timing of malaria medication or diagnostics used; and whether the patient took anti-malaria
drugs while receiving antiretroviral therapy (see S1 Appendix). The survey was created in
English and translated into Igbo and Pidgin English by the study researchers. Pre-test data
were not included as part of the present study. Adjustments were made after pre-testing, before
the questionnaire was used for study data collection.
Data collection
Data were collected using the structured, pre-tested questionnaire by a team of trained research
assistants under the supervision of study investigators. To each study participant, the study was
first introduced, and the objectives elucidated. Informed verbal consent was also sought and
obtained before the questionnaire was administered. Literate respondents self-administered the
survey in either English, Igbo, or “Pidgin English”. Research assistants stayed on hand to clarify
points of confusion and collected the questionnaires immediately after completion. For patients
who could not self-administer the survey either due to illness or lack of literacy, the research
assistants verbally administered the questionnaire to them in the local (Igbo) language, English
or “Pidgin English” based on the subjects’ choice. The responses were then immediately trans-
lated and/or transcribed into English and filled out on the questionnaire by the trained research
assistant. Data collection occurred over a one-month period (see S1 Table).
Data analysis
Initial analysis consisted of calculating descriptive statistics to create percentage and frequency
tables. Pearson’s chi-squared test (χ2) was performed to examine associations between com-
pleting anti-malarial treatments, patterns of reported suspected malaria (re)-occurrence, and
having adverse reactions to simultaneous ART and malaria treatment. We also performed
multivariate logistic regression to assess associations between socio-demographic factors such
as educational attainment, urban residence, and gender and the use of formal or recom-
mended healthcare services for malaria diagnosis and treatment. Probability values (p) less
than or equal to 5% were considered statistically significant. Analyses were performed on
IBM-SPSS Statistics version 23 and Stata version 14.
Variables of interest
Respondents were said to have used “formal” services if they received treatment at licensed
pharmacies, general clinics or hospitals, or HIV care centres. Using microscopy, rapid tests, or
a clinical exam for diagnosis was considered receiving a formal diagnosis and getting a medica-
tion prescription from a clinician rather than self-medicating or purchasing medication from
drug-shops was considered using formal prescription services. Respondents who answered,
“self-treatment at home” to the question of “What action do you take when you suspect
malaria?” were considered to be self-treating. Patients were asked to name the drugs that they
used for treating malaria. If they selected an artemisinin-based compound combined with a
drug from a different class, they were coded as using ACTs. Respondents were asked directly
whether they took antiretrovirals and anti-malarial simultaneously and which kind of adverse
event (e.g., nausea, rash) related to their treatment they had experienced. If they selected any
of the adverse events from the list, they were considered as having had an adverse event. These
Malaria care-seeking behaviour among HIV patients
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six measures were coded as dichotomous outcome variables for our multivariate logistic
regression analysis of factors associated with healthcare seeking behaviour.
Ethical approval
Ethical approval was given by the Ethical Committee of the School of Health Technology, Fed-
eral University of Technology Owerri, Nigeria. Permission was also sought and obtained from
the management of Imo State Specialist Hospital Owerri and the Federal Medical Centre
Owerri, South Eastern Nigeria. Informed verbal consent as permitted by the Ethical Commit-
tee was sought and obtained from all the participants before they could take part in the study.
Research assistants read informed consent form material to participants and noted the respon-
dents’ consent on the form when given. Verbal consent was obtained instead of written con-
sent because of concerns about patient literacy and protecting patient confidentiality
considering the heavy stigma that HIV-infection can carry in this region.
Results
Socio-demographic characteristics
Table 1 shows the socio-demographic characteristics of the sample. A total of 398 PLWHA
participated: 210 (53%) from Federal Medical Centre (FMC) and 188 (47%) from Imo State
Specialist Hospital (IMSSH). Our response rate was 97.3%. There were slightly more women
than men in the study sample: 221 males (46%) and 259 females (54%). More than half of the
subjects (55%) were married, 36% were single, 7.5% divorced, and 1.5% widowed. The sample
was relatively well educated, with 57% having achieved a secondary school education or
higher. The relatively high socio-economic status is reflected in reported income, with more
than half of the sample reporting income well above Nigeria’s poverty line. The majority were
employed in the public sector or in trading or small businesses (see Table 1).
HIV status
There were very few newly HIV-diagnosed patients; only 11% had lived with HIV for less than
a year; 48% had been aware of their status for 1–5 years and 38% for 6–10 years (see Table 1).
Almost all (98%) were currently taking ART but only 39% of patients receiving ART knew
which drugs were used for their therapy.
Patterns of self-malaria occurrence
Table 2 reports the extent of malaria occurrence reported among the HIV/AIDS patients stud-
ied. All study subjects said they had experienced malaria while receiving HIV/AIDS care.
More than one-third (36%) of HIV-infected patients had a reported malaria occurrence every
month and 43% and 16% respectively reported experiencing malaria on a quarterly and yearly
basis.
Patient reaction to suspicion of malaria
Few patients sought appropriate, formal care when they suspected that they had malaria. The
plurality (39%) used drug shops to buy malaria drugs from shop attendants when they sus-
pected an attack and most others (29%) self-treated at home. Only 23% reported their suspi-
cion to their HIV/AIDS care centres for proper diagnosis (see Table 3). Most respondents
(57%) said that they acted within 24 hours of a suspected malaria occurrence.
Malaria care-seeking behaviour among HIV patients
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Table 1. Socio-demographic characteristics.
Characteristics Frequency (n = 398) Percent
Location
FMC OW 210 52.8
IMSSP 188 47.2
Gender
Male 160 40.2
Female 238 59.8
Age (in years)
� 25 102 25.6
26–35 176 44.2
36–45 78 19.6
�46 32 8.0
Non-response 10 2.5
Marital status
Single 144 36.2
Married 218 54.8
Divorced 30 7.5
Widowed 6 1.5
Education
Tertiary 118 29.6
Secondary 190 47.7
Primary 68 17.1
Non-formal 22 5.5
Occupation
Student 140 35.2
Business 194 48.7
Public servants 48 12.1
Artisans 10 2.5
Others 4 1.0
Non-response 2 0.5
Monthly income (naira)
� 18,000 184 46.2
19,000–60,000 208 52.3
61,000–100,000 6 1.5
� 100,000 0 0.0
Duration lived with HIV
< 1 year 44 11.1
1–5 years 192 48.2
6–10 years 152 38.2
>10 years 10 2.5
Receiving antiretroviral therapy
Yes 390 98.0
No 8 2.0
Knowledge of the drugs used for their therapy
Yes 156 39.2
No 238 59.8
Non-response 4 1.0
https://doi.org/10.1371/journal.pone.0213742.t001
Malaria care-seeking behaviour among HIV patients
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When seeking formal confirmation for suspected malaria an almost equal proportion rely
on clinical examination (42%) or laboratory tests (27% microscopy, 16% rapid diagnostic
tests). Approximately 12% do not use any form of formal confirmation of diagnosis.
Self-treatment was less prevalent among respondents with no formal schooling
(AOR = 0.21; 95% CI = 0.05,0.95) than among those who had completed primary, secondary,
or tertiary schooling. There was also some indication that men in this sample were less likely
to self-treat than women although this association was only significant at the 10% level
(AOR = 0.66; 95% CI = 0.41,1.05).
Malaria treatment drugs: Sources, types and usage patterns
Only a small minority of patients received their malaria treatment medications from the for-
mal sector (see Table 4). More than half (54%) of study subjects said that their primary source
Table 3. Reaction on suspicion of malaria.
Reaction/ Behaviour Frequency (n = 398) Percent
Action taken on suspicion of malaria attack
Self-treatment at home 116 29.1
Go to drug-shop 156 39.2
Report to HIV/AIDS care centre 90 22.6
Go for medical laboratory diagnosis 34 8.5
Others 2 0.5
Time taken to commence treatment of suspected malaria
� 24 hours 226 56.8
� 24 hours 150 37.7
Can’t remember 20 5.5
Usual method of confirmation of suspected malaria
Microscopy test 108 27.1
Rapid diagnostic test 64 16.1
Doctors clinical examination 168 42.2
No confirmation 48 12.1
Other 4 1.0
Non-response 6 1.5
Anti-malaria drugs prescriber
Self 214 53.8
Drug shop owners 106 26.6
Doctor 64 16.1
Friend/relative 14 3.5
https://doi.org/10.1371/journal.pone.0213742.t003
Table 2. Self-reported experiences of suspected malaria.
Frequency (n = 398) Percent
Have ever had malaria (suspected)
Yes 398 100
No 0 0.0
Frequency of suspected malaria occurrence
Monthly 142 35.7
Quarterly 172 43.2
Yearly 64 16.1
Other 20 5.0
https://doi.org/10.1371/journal.pone.0213742.t002
Malaria care-seeking behaviour among HIV patients
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of anti-malaria drugs was drug shops. Slightly less than a third (28%) used licensed pharmacies
to purchase drugs, and only 16% received medications from clinics/hospitals. HIV clinics were
rarely used as a source of medication. We found no significant differences in the use of formal
vs. informal sources for purchasing malaria treatment medications by gender, educational
level or urban residence (See Table 5).
Most patients reported using recommended malaria treatment medications, with 60% say-
ing that they used ACTs for treatment. However, a significant minority (26%) only used anti-
pyretics (usually paracetamol) and other almost 10% used a non-ACT anti-malaria
medication. Use of traditional medicines was low, with only 3.5% saying that they used herbs.
The most common ACT regimens used were artemether/lumefantrine (60%) which is the
treatment recommended by the Nigerian Ministry of Health, [26] artesunate/amodiaquine
(28%), and dihydroartemisinin/piperaquine (11%). Respondents with tertiary education were
more likely to use ACTs for malaria treatment than those with no formal schooling
[AOR = 1.82; 95% CI: 1.11, 3.00]. Older respondents were significantly more likely to use ACT
than the youngest age group: AOR = 2.11 (95% CI: 1.27, 3.52) for the 26–35 years age group,
and AOR = 2.77 for the oldest age group, (95% CI: 1.17, 6.59) (See Table 5).
Approximately 80% of patients said that they usually complete their chosen malaria treatment
course. Those who reported very frequent (monthly) or very infrequent (annual) suspected
malaria occurrences were significantly more likely to complete their malaria treatments (p = 0.03)
than those who reported quarterly occurrences (see Table 6). We found no significant socio-demo-
graphic differences in reported completion by type of malaria treatment regimen (See Table 5).
We found that 62.8% of respondents said that they did not take their chosen anti-malaria
drugs while they were taking their antiretroviral drugs. Respondents who took herbs or
Table 4. Malaria treatment medication: Sources, types and usage patterns.
Assessment Frequency (n = 398) Percent (%)
Source of anti-malaria drug
Drug shop 216 54.3
Licensed pharmacy 110 27.6
Clinic/hospital 64 16.1
HIV/AIDS care centre 8 2
Primary drug used for malaria treatment
ACT 240 60.3
Antipyretics (paracetamol) 102 25.6
Other anti-malaria drugs (not ACT) 38 9.5
Herbs 14 3.5
Other treatments 4 1
ACT type used if ACT (n = 240)
Arthemeter/lumefantrine 144 60.0
Artesunate/amodiaquine 66 27.6
Dihydroartemisinin/piperaquinet 26 10.8
Arthesunate + mefloquine 2 0.8
Chloroguanil+dapsone+artesunate 2 0.8
Completion of malaria treatment
Yes 320 80.4
No 78 19.6
Takes anti-malaria drug & ART at the same time
Yes 148 37.2
No 250 62.8
https://doi.org/10.1371/journal.pone.0213742.t004
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alternative drugs had significantly higher odds of continuing ART while taking malaria treat-
ment than those taking ACTs. The adjusted odds of not stopping ART were 6.14 (95% CI:
1.73, 21.80) for patients who took herbs to treat their malaria and 3.94 (95% CI: 1.88, 8.26) for
patients who took non-ACT malaria treatments (See Table 5). Respondents who took artesu-
nate/amodiaquine for treatment had lower odds of continuing ART than those on other regi-
mens (AOR = 0.53; 95% CI: 0.31, 0.91).
Self-reported suspected malaria occurrence patterns and adverse events
Approximately one-fifth of respondents experienced adverse events related to malaria and
HIV treatment. We performed a chi-square test to examine the relationship between these
events and the frequency of self-reported suspected malaria, and found that the percentage of
participants reporting adverse events differed significantly by self-reported malaria occurrence
pattern (p<0.0001; χ2 = 24.5) with 22.5% of those who self-report having monthly bouts of
suspected malaria reporting adverse events, 14.0% of those with reported quarterly attacks,
and 18.8% of those reporting annual attacks respectively (see Table 7).
Urban respondents (AOR = 3.69, 95%CI: 2.05, 6.44) were more likely to report adverse
events than rural and respondents in the middle age groups than the youngest age group
(AOR = 4.17 95%CI: 1.783, 9.769 for the 26–35 age group and AOR = 3.66, 95%CI: 1.370,9.754
for the 36–45 age group) (see Table 5). Those with less education had a lower likelihood of
reporting adverse events (AOR = 0.213, 95%CI: 0.07, 0.64 for those with primary education
compared to those with secondary education) (see Table 5).
Patient recommendations for improving management of malaria/HIV co-
infection
Almost none of the respondents (87%) could provide a recommendation for ways to improve
malaria prevention and treatment for PLWHA. The few suggested actions that were offered
Table 6. Self-reported suspected malaria occurrence pattern and completion of treatment.
Self-Reported Suspected Malaria Frequency
Monthly Quarterly Yearly Other p-value�
n = 142 n = 172 n = 64 n = 20
Complete treatment?
Yes 112 (78.9%) 148 (86.0%) 44 (68.8%) 16 (80.0%) 0.03
No 30 (21.1%) 24 (14.0%) 20 (31.2%) 4 (20.0%)
�Chi-squared test. “Other” includes those who reported having malaria but who were not sure of how often they
experienced it.
https://doi.org/10.1371/journal.pone.0213742.t006
Table 7. Self-reported suspected malaria occurrence pattern and adverse events.
Self-Reported Suspected Malaria Frequency
Monthly Quarterly Yearly Other p-value�
n = 142 n = 172 n = 64 n = 20
Adverse event
Yes 32 (22.5%) 24 (14.0%) 12(18.8%) 12 (60.0%) <0.0001
No 110(77.5%) 148(86.0%) 52 (81.2%) 8(40.0%)
�Chi-squared test. “Other” includes those who reported having malaria but who were not sure of how often they
experienced it.
https://doi.org/10.1371/journal.pone.0213742.t007
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were combining malaria treatment with HIV drugs (1%), suspending antiretroviral drugs
while on malaria treatment (7%), and using treated mosquito nets to prevent further mosquito
bites (4%) (see Table 8).
Discussion
This study examined malaria care-seeking behaviour among HIV/AIDS patients receiving
antiretroviral therapy in Southeastern Nigeria. We found extremely high levels of self-reported
co-infection with all patients reporting having had suspected malaria and almost 80% report-
ing a suspected re-occurrence on at least a quarterly basis. Our data suggest that most of these
suspected cases are never formally diagnosed but rather assumed to be malaria and treated as
such. This highlights the need for greater access to rapid diagnostic tests, which were only used
by 16.1% of our sample.
The rate of malaria co-infection reported by our study participants is higher than that
found in other sub-Saharan African settings [27], which is likely a reflection of the self-
reported nature of our study data. We simply asked participants if they had suffered from
malaria and how often, rather than conducting parasitological diagnosis of malaria infection.
The population in this area of Nigeria is exposed to a host of infectious agents that might cause
malarial symptoms that participants may have mistakenly attributed to malaria. Our estimate
of malaria occurrence in this population is, therefore, quite imprecise and most likely an
overestimate.
We found heavy use of informal sources such as drug shop sellers and home-care for imme-
diate treatment on suspicion of malaria. Self-medication and use of informal drug sellers are
well documented among the general population in Nigeria [28, 29] and sub-Saharan Africa
[30–32] and the rates reported here are in keeping with this literature. For example, this pat-
tern of care is consistent with results from a study among HIV-infected pregnant women in
Nigeria [33] that showed that half of the women self-prescribed anti-malaria drugs. The high
cost of formal care, desensitization due to the high prevalence of malaria, shortages of drugs,
and perceived low-quality care at formal facilities have been found as explanations for this phe-
nomenon [31, 34].
What is surprising is that this study sample, which has steady access to relatively well-
resourced health facilities, has treatment patterns like those found in the general public. This
highlights the importance of drug cost (unlike antiretroviral drugs, malaria medications are
not provided free of charge at HIV clinics in Nigeria), and of convenience factors in driving
healthcare-seeking behaviour. The finding that self-treatment was more common among
respondents in our study with higher levels of education lends additional support to the argu-
ment that convenience and quality of care are important drivers of self-treatment.
Our findings regarding the heavy use of drug sellers and private laboratories also under-
score the continued importance of engaging the private sector in HIV/AIDS and malaria
Table 8. Patient recommendations for improving management of malaria/HIV Co-infection.
Recommendations Frequency (n = 398) Percent
(%)
Combine malaria treatment with HIV Drugs 4 1.0
Suspend use of HIV drugs while on malaria treatment 28 7.0
Use of treated mosquito net 16 4.0
Constant testing against malaria 2 0.5
Don’t Know 348 87.4
Total 398 100
https://doi.org/10.1371/journal.pone.0213742.t008
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program development and of pursuing community-based treatment strategies to improve
access to appropriate treatment. Our study and others indicate that there is a broad range of
healthcare stakeholders in both the public and private sectors that are involved in malaria con-
trol among HIV-infected patients, including hospital clinics, pharmacies, private clinics, and
patent medicine stores. For example, a recent Nigerian study reported that the private sector
took care of more than 43% of malaria cases [35].
We find that the majority of patients using anti-malaria medications (as opposed to drugs for
symptom relief) reported using the first-line, recommended ACTs. There were few reports of
mono-therapy or of ineffective treatment, and approximately 80% of patients said that they fin-
ished their course of treatment. Although the quality of these medications is unknown as many
were purchased privately, it is still heartening to find that newer, recommended treatment regi-
mens are widely available and being taken. We must note, however, that a significant minority
of respondents took only paracetamol, sub-optimal anti-malarial treatments, or herbal remedies.
We note two areas of concern regarding HIV and malaria co-treatment. First, many
patients report using ACT regimens containing drugs (e.g., amodiaquine) that interact with
the antiretroviral drugs included in Nigeria’s first line ART regime (namely, efavirenz). A sig-
nificant minority of study patients combine anti-malaria drugs with ART, suggesting a risk for
adverse events. In addition, patients were more likely to continue ART when they were taking
non-ACT anti-malaria medication or herbal remedies (which may explain why less educated
patients were more likely to report continuing ART than their more educated counterparts).
The association between continuing ART and using traditional or non-ACT medications may
be due to patients experiencing fewer drug interactions when taking these alternative medica-
tions or to them perceiving alternative regimens as relatively safer or milder and, therefore,
being less afraid of remaining on ART while taking them. Other studies in sub-Saharan Africa
have found that HIV-infected patients do concurrently use herbal treatment while on ART for
perceived minor ailments (including malaria) in the belief that it increases their energy and
immunity [36]. Although the number of people using traditional medication to treat malaria is
low in our sample (which is in keeping with the figures reported in other studies of patients on
ART [36]), our findings suggest that there may be potential, under-appreciated risk of interac-
tion between traditional medication and ART in this population. The use of traditional medi-
cines in patients who are taking ART and/or anti-malarial warrants further study, preferably
using in-depth, qualitative methods that can better illuminate their beliefs and their decision-
making processes than quantitative surveys such as ours.
Another concerning finding was that 80% of patients stopped taking ART when they
started malaria treatment—a behaviour that increases the risk of resistance to antiretroviral
medications and leads to poor viral load suppression. Moreover, the responses (or lack thereof)
to the question asking for suggestions about to improve care, suggest that patients did not
know the proper course of action for managing co-infection. Given the complexities of malaria
treatment in patients receiving ART and the extremely high self-reported malaria incidence,
more effort must be made to strengthen and develop new malaria prevention interventions
and to better integrate them into HIV/AIDS care. Effective prevention interventions exist. For
example, we know that co-infection is significantly lower among patients who use insecticide-
treated bed nets and co-trimoxazole chemotherapy [9, 37]. Even if a significant proportion of
HIV-infected patients in this study were not truly co-infected, mistaking a fever for malaria, if
they self-medicate or adjust their HIV treatment as though they were co-infected, their health
could be compromised.
A surprising finding is that most of the subjects studied knew the names of the drugs they
use to treat malaria. This contrasts with findings in a recent Nigerian study [33], in which
many of co-infected pregnant women stated that they never had any knowledge of intermittent
Malaria care-seeking behaviour among HIV patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0213742 May 9, 2019 12 / 16
preventive treatment. This difference may be due to the relatively well-educated sample and
their tendency to self-treat, which requires that they know the names of their medication.
The finding that almost no study respondents could give suggestions for managing or pre-
venting co-infection suggests that the structure of counselling sessions may not provide
enough time to discuss such topics and provide updates. More comprehensive counselling ses-
sions using techniques such as question and answer sessions and video recordings might help
to fill gaps in patient knowledge. Providers and HIV clinic management staff should also
develop systems to more closely track which malaria drugs are being used by patients.
Limitations
This study is limited by its narrow geographic scope and modest sample size and non-random
sample selection strategy, which reduces its generalizability. The study is subject to both recall
and social desirability bias as respondents may not remember past malaria episodes or treat-
ment behaviour accurately and may report the health-seeking behaviour that they perceive as
desirable. Problems with recall may be exacerbated by the fact that patients with a serious, life-
threatening illness may be under great physical and emotional stress, which may impair mem-
ory. We attempted to address recall bias by having data collectors on-hand to reword or repeat
questions, and prompt memory but this, in turn, may have introduced measurement error if
questions were explained differently by different data collectors. The lack of back-translation
of our survey instrument may have also introduced measurement error. Social desirability
bias, if it occurred would have most likely lead to an under-reporting of the significant levels of
informal care reported by participants. Finally, as noted at the start of this discussion, our esti-
mates of malaria occurrence are based on self-report rather than diagnosis and, therefore, not
precise. While this limits our ability to measure the level of co-infection in this population it
does not greatly limit our ability to describe the care-seeking behaviour of these HIV-infected
patients when they suspected that they have malaria.
Conclusion
This study has shown that PLWHA receiving ART in our sample self-report extremely high
levels of suspected malaria, and that very little of their subsequent malaria care occurs in the
formal sector. More worryingly, frequent bouts of suspected malaria seem to lead to interrup-
tions in ART as most patients do not take ART and anti-malaria drugs simultaneously.
Patients who do continue ART while treating malaria often use alternative, non-ACT anti-
malaria drugs or herbal remedies, neither of which would tend to have well documented drug-
drug interaction profiles with antiretroviral drugs. Our findings suggest the need for more
research on ART-ACT interactions; better outreach to community-level drug shops and other
private-sector stakeholders; and clearer guidelines for clinicians and patients on monitoring
and managing co-infection. Wider access to rapid malaria diagnostic tests might also reduce
the high level of presumptive malaria self-treatment that we find. Providing anti-malaria drugs
for free in HIV care programs may also be worth exploring. Overall, we suggest that malaria
prevention and control be viewed as an important element in the treatment HIV/AIDS
patients in malaria-endemic countries such as Nigeria. This will require improved collabora-
tion between programs for both diseases.
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